Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $33M seed (Mar 2026). Owkin Dx spinout. Multimodal oncology AI analyzing pathology images + clinical data for treatment decisions. Positioned against Tempus and Foundation Medicine.
Waiv is a digital pathology AI company spun out of Owkin's diagnostic unit in March 2026 with a $33 million seed round, inheriting Owkin's proven multimodal oncology AI stack that has been validated in multiple peer-reviewed publications and clinical collaborations with major academic medical centers. The platform analyzes H&E-stained pathology slide images combined with genomic, clinical, and outcomes data to extract prognostic and predictive biomarkers that help oncologists select optimal treatments for individual cancer patients.
Japanese automaker with $89B revenue in Renault-Nissan Alliance; LEAF electric vehicle pioneer facing restructuring and Honda merger discussions amid China market and profit challenges.
Nissan Motor Co. is a Japanese multinational automobile manufacturer producing passenger cars, SUVs, trucks, and electric vehicles under the Nissan, Infiniti (luxury), and Mitsubishi (partnership) brands. Founded in 1933 in Yokohama, Japan and listed on the Tokyo Stock Exchange, Nissan generates approximately $89 billion (¥12.9 trillion) in annual revenue and is one of the world's largest automakers. Nissan has been part of the Renault-Nissan-Mitsubishi Alliance since 1999 — a cross-shareholding partnership that shares platforms, technology, and procurement.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.